Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive comparison of the prognostic value of systemic inflammation biomarkers for cancer cachexia: a multicenter prospective study
Hailun Xie, Guo‐Tian Ruan, Lishuang Wei, et al.
Inflammation Research (2022) Vol. 71, Iss. 10-11, pp. 1305-1313
Closed Access | Times Cited: 17

Showing 17 citing articles:

Current Therapeutic Targets in Cancer Cachexia: A Pathophysiologic Approach
Kunal C. Kadakia, Jill Hamilton‐Reeves, Vickie E. Baracos
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Closed Access | Times Cited: 35
AWGC2023 cachexia consensus as a valuable tool for predicting prognosis and burden in Chinese patients with cancer
Hailun Xie, Lishuang Wei, Guo‐Tian Ruan, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 15, Iss. 5, pp. 2084-2093
Open Access | Times Cited: 4
Relationship between nutritional-inflammatory markers and postoperative outcomes in ovarian cancer: a retrospective study
Ying Zhang, Xing Wen, Xiaoyi Liang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies
Sven H. Loosen, Markus S. Jördens, Berenike Schoon, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 9, pp. 6181-6190
Open Access | Times Cited: 10
The differential effects of sarcopenia and cachexia on overall survival for pancreatic ductal adenocarcinoma patients following pancreatectomy: A retrospective study based on a large population
Xiaoding Shen, Xing Wang, Zhenjiang Zheng, et al.
Cancer Medicine (2023) Vol. 12, Iss. 9, pp. 10438-10448
Open Access | Times Cited: 9
Improving the assessment of malnutrition in cancer: Using systemic inflammation markers as a supplement to the inflammation items of the GLIM criteria
Hailun Xie, Kaitao Yuan, Guo‐Tian Ruan, et al.
Clinical Nutrition (2023) Vol. 42, Iss. 10, pp. 2036-2044
Closed Access | Times Cited: 9
Ursolic acid alleviates cancer cachexia by inhibiting STAT3 signaling pathways in C2C12 myotube and CT26 tumor-bearing mouse model
L. Chen, Yan Chen, Mengxia Wang, et al.
European Journal of Pharmacology (2024) Vol. 969, pp. 176429-176429
Closed Access | Times Cited: 3
Evaluation and validation of neutrophil to albumin ratio as a promising prognostic marker for all-cause mortality in patients with cancer: a multicenter cohort study
Hailun Xie, Pingping Jia, Lishuang Wei, et al.
Nutrition (2024) Vol. 121, pp. 112365-112365
Closed Access | Times Cited: 2
Development of Nomogram Models Based on Peripheral Blood Score and Clinicopathological Parameters to Predict Preoperative Advanced Stage and Prognosis for Epithelial Ovarian Cancer Patients
Gaigai Bai, Yue Zhou, Rong Qing, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 1227-1241
Open Access | Times Cited: 6
Relevance of Dietary Supplement Use in Gastrointestinal-Cancer-Associated Cachexia
Saunjoo L. Yoon, Oliver Grundmann
Nutrients (2023) Vol. 15, Iss. 15, pp. 3391-3391
Open Access | Times Cited: 6
Individualized threshold of the involuntary weight loss in prognostic assessment of cancer
Hailun Xie, Heyang Zhang, Guo‐Tian Ruan, et al.
Journal of Cachexia Sarcopenia and Muscle (2023) Vol. 14, Iss. 6, pp. 2948-2958
Open Access | Times Cited: 5
Modified Controlling Nutritional Status (mCONUT) serves as a promising prognostic factor in patients with cancer cachexia
Xi Zhang, Jiaxin Huang, Meng Tang, et al.
Nutrition (2023) Vol. 117, pp. 112229-112229
Closed Access | Times Cited: 4
Phase Angle: A Robust Predictor of Malnutrition and Poor Prognosis in Gastrointestinal Cancer
Jiajun Yang, Hailun Xie, Lishuang Wei, et al.
Nutrition (2024) Vol. 125, pp. 112468-112468
Closed Access | Times Cited: 1
Performance of anthropometry-based and bio-electrical impedance-based muscle-mass indicators in the Global Leadership Initiative on Malnutrition criteria for predicting prognosis in patients with cancer
Hailun Xie, Lishuang Wei, Guo‐Tian Ruan, et al.
Clinical Nutrition (2024) Vol. 43, Iss. 7, pp. 1791-1799
Closed Access | Times Cited: 1
Longitudinal Muscle Biopsies Reveal Inter- and Intra-Subject Variability in Cancer Cachexia: Paving the Way for Biopsy-Guided Tailored Treatment
Panagiotis Filis, Nikolaos P. Tzavellas, Dimitrios Stagikas, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 1075-1075
Open Access
Leptin as a surrogate immune-metabolic marker to predict impact of anti-cachectic therapy: results of a prospective randomized trial in multiple solid tumors
Clelia Madeddu, Giulia Gramignano, Eleonora Lai, et al.
ESMO Open (2024) Vol. 9, Iss. 10, pp. 103738-103738
Open Access
Carnosol analogue WK-63 alleviated cancer cachexia by inhibiting NF-κB and activating AKT pathways in muscle while inhibiting NF-κB and AMPK pathways in adipocyte
Xiaojuan Pan, Gang Zhang, Kun Wei, et al.
Toxicology and Applied Pharmacology (2023) Vol. 479, pp. 116729-116729
Closed Access
Page 1

Scroll to top